Research Article
The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9
Table 1
Relationships between clinicolaboratory characteristics and the modified Glasgow prognostic score (mGPS).
| | | mGPS = 0
n (%) | mGPS = 1
n (%) | mGPS = 2
n (%) | value† |
| | Sex | | Male | 297 (88.1) | 19 (5.7) | 21 (6.2) | 0.132 | | Female | 142 (94.0) | 4 (2.6) | 5 (3.4) |
| | Age (years) | | <65 | 239 (93) | 7 (2.7) | 11 (4.3) | 0.044 | | ≥65 | 200 (86.6) | 16 (6.9) | 15 (6.5) |
| | Body mass index (kg (m2)−1) | | <25 | 351 (88.9) | 19 (4.8) | 25 (6.3) | 0.057 | | ≥25 | 88 (94.6) | 4 (4.3) | 1 (1.1) |
| | Tumor location | | Upper third | 139 (88) | 7 (4.4) | 12 (7.6) | 0.578 | | Middle third | 176 (91.7) | 8 (4.2) | 8 (4.2) | | Lower third | 124 (89.9) | 8 (5.8) | 6 (4.3) |
| | Hemoglobin (g/L) | | <12 | 174 (82.1) | 16 (7.5) | 22 (10.4) | <0.001 | | ≥12 | 265 (96.0) | 7 (2.5) | 4 (1.4) |
| | White cell count (×109 L−1) | | <11 | 436 (91.6) | 19 (4.0) | 21 (4.4) | <0.001 | | ≥11 | 3 (25.0) | 4 (33.3) | 5 (41.7) |
| | Neutrophils (×109 L−1) | | <7.5 | 431 (91.7) | 21 (4.5) | 18 (3.8) | <0.001 | | ≥7.5 | 8 (44.4) | 2 (11.1) | 8 (44.4) |
| | Lymphocytes (×109 L−1) | | <3 | 420 (90.1) | 21 (4.5) | 25 (5.4) | 0.668 | | ≥3 | 19 (86.4) | 2 (9.1) | 1 (4.5) |
| | TNM | | Ib | 65 (94.2) | 3 (4.3) | 1 (1.4) | 0.357 | | II | 124 (89.2) | 6 (4.3) | 9 (6.5) | | III | 148 (91.9) | 7 (4.3) | 6 (3.7) | | IV | 102 (85.7) | 7 (5.9) | 10 (8.4) |
|
|
†χ2 test.
|
